Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
4
×
biotech
life sciences
national blog main
abbvie
clinical trials
boston blog main
crispr
deals
editas medicine
europe blog main
fda
national
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco blog main
abide therapeutics
akouos
alnylam pharmaceuticals
alzheimer's disease
amag pharmaceuticals
amgen
amunix
amylin pharmaceuticals
anirvan ghosh
astrazeneca
ben cravatt
biogen
biohaven
bluerock therapeutics
boston
boston top stories
botox
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
What
medicines
4
×
treat
treatment
abbvie
abide
acquisitions
adults
allergan
alliance
announced
appointed
approved
bio
biotech
ceo
chief
class
collabs
covid
daniel
deal
developing
diseases
editas
editing
executive
exits
experimental
fda
finney
gene
genetic
gilead
gilead’s
help
introduce
ipo
kevin
migraine
monday
Language
unset
Current search:
allergan
×
medicines
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President
